Companies / Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc.
NYSE: CATXCIK 728387SEATTLE, WA
Financials · FY2022
Ownership
114.2M shares outstanding · as of Aug 5, 2026
Ownership
| 10%+ / strategic | 11.50% | 13,125,079 |
| Institutions | 40.54% | 46,282,224 |
| Public float | 47.96% | 54,744,360 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all →| Insider | % of shares | Shares |
|---|---|---|
Henson HeidiDirector | — | — |
Hunt Jonathan RobertChief Accounting Officer | — | — |
Martinez Maria EDirector | — | — |
Morich FrankDirector | — | — |
Puhlmann MarkusChief Medical Officer | — | — |
Spoor Johan M.CEOChief Executive Officer · Director | — | — |
Williamson Robert F IIIDirector | — | — |
Woods Lori ADirector | — | — |
Institutional holders 126
View all →| Holder | Value | % of shares |
|---|---|---|
| $32.38M | 8.32% | |
| $20.64M | 5.30% | |
| $16.87M | 3.54% | |
| $12.49M | 2.62% | |
| $12.30M | 3.92% | |
| $9.60M | 3.06% | |
| $8.83M | 2.81% | |
| $7.37M | 1.55% | |
| $4.99M | 1.04% | |
| $4.45M | 1.42% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Puhlmann Markus Executive | Grant | Stock option (right to buy) | — | +150K | 150,000 0.13% of shares | low |
| Mar 2, 2026 | Martinez Maria E Director | Grant | Stock option (right to buy) | — | +50K | 50,000 0.04% of shares | low |
| Mar 2, 2026 | Morich Frank Director | Grant | Stock option (right to buy) | — | +50K | 50,000 0.04% of shares | low |
| Mar 2, 2026 | Spoor Johan M. CEO | Grant | Stock option (right to buy) | — | +735K | 735,000 0.64% of shares | low |
| Mar 2, 2026 | Williamson Robert F III Director | Grant | Stock option (right to buy) | — | +50K | 50,000 0.04% of shares | low |
| Mar 2, 2026 | Woods Lori A Director | Grant | Stock option (right to buy) | — | +50K | 50,000 0.04% of shares | low |
| Mar 2, 2026 | Hunt Jonathan Robert Executive | Grant | Stock option (right to buy) | — | +90K | 90,000 0.08% of shares | low |
| Mar 2, 2026 | Henson Heidi Director | Grant | Stock option (right to buy) | — | +50K | 50,000 0.04% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| State Street Corporation | Passive13G | — |
| Qatar Investment Authority | Passive13G | — |
| Avidity Partners Management LP | Passive13G | — |
| Commodore Capital LP | Passive13G | — |
| TCG Crossover GP II, LLC | Passive13G | — |
| Morgan Stanley | Passive13G | — |
| Millennium Management LLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CATX | — | 46489V302 |